18Feb/14

Global Bone Marrow Transplantation Analysis and Market Growth, Trend … – Virtual-Strategy Magazine (press release)

Global Bone Marrow Transplantation Analysis and Market Growth, Trend
Virtual-Strategy Magazine (press release)
Global Markets Directs, ‘Bone Marrow Transplantation Pipeline Review, H1 2014′, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bone Marrow Transplantation, complete with 

and more »

18Feb/14

Global Bone Marrow Transplantation Analysis and Market Growth, Trend … – PR Web (press release)

Global Bone Marrow Transplantation Analysis and Market Growth, Trend
PR Web (press release)
Global Markets Directs, ‘Bone Marrow Transplantation Pipeline Review, H1 2014′, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bone Marrow Transplantation, complete with 

and more »

17Feb/14

Have scientists figured out how to reverse the process of ageing? – India.Com Health


India.Com Health

Have scientists figured out how to reverse the process of ageing?
India.Com Health
Right now the only cost beneficial stem cell therapy is bone marrow transplantation but experts believe that it can be soon used to treat cancer, diabetes, Parkinson’s, cardiac failures and can facilitate organ transplantation with minimal risk of

and more »

17Feb/14

Deep TCR Sequencing Reveals Extensive Renewal of the T Cell Repertoire … – Newswise (press release)

Deep TCR Sequencing Reveals Extensive Renewal of the T Cell Repertoire
Newswise (press release)
In the Immune Tolerance Network’s (ITN) HALT-MS study, 24 patients with relapsing, remitting multiple sclerosis received high-dose immunosuppression followed by a transplant of their own stem cells, called an autologous stem cell transplant, to

17Feb/14

Extensive renewal of the T cell repertoire following autologous stem cell … – EurekAlert (press release)

Extensive renewal of the T cell repertoire following autologous stem cell
EurekAlert (press release)
In the Immune Tolerance Network’s (ITN) HALT-MS study, 24 patients with relapsing, remitting multiple sclerosis received high-dose immunosuppression followed by a transplant of their own stem cells, called an autologous stem cell transplant, to

and more »